Free Trial

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Galp Energia SGPS stock logo

1. Galp Energia SGPS OTCMKTS:GLPEY

$9.30 -0.03 (-0.32%)
As of 12:52 PM Eastern

Galp Energia, SGPS, SA operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Midstream, Commercial, and Renewables and New Business. More about Galp Energia SGPS

Market Capitalization
$12.93 billion
P/E Ratio
13.10
Consensus Rating
Strong Buy
Volume
16,864 shares
Average Volume
77,613 shares
Today's Range
$9.29
$9.35
Birchcliff Energy stock logo

2. Birchcliff Energy OTCMKTS:BIREF

$4.29 -0.03 (-0.69%)
As of 12:55 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.17 billion
P/E Ratio
22.58
Consensus Rating
Strong Buy
Volume
3,023 shares
Average Volume
77,925 shares
Today's Range
$4.29
$4.37
Ivanhoe Mines stock logo

3. Ivanhoe Mines OTCMKTS:IVPAF

$9.32 -0.56 (-5.67%)
As of 12:59 PM Eastern

Ivanhoe Mines Ltd. engages in the mining, development, and exploration of minerals and precious metals primarily in Africa. More about Ivanhoe Mines

Market Capitalization
$12.62 billion
P/E Ratio
18.84
Consensus Rating
Strong Buy
Volume
158,679 shares
Average Volume
322,206 shares
Today's Range
$9.31
$9.92
Glencore stock logo

4. Glencore OTCMKTS:GLNCY

$8.28 -0.01 (-0.12%)
As of 12:55 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about Glencore

Market Capitalization
$49.18 billion
Consensus Rating
Strong Buy
Volume
129,047 shares
Average Volume
951,812 shares
Today's Range
$8.24
$8.33
50-Day Range
$7.54
$8.84
Senseonics stock logo

5. Senseonics NYSE:SENS

$0.46 +0.01 (+2.35%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$373.12 million
P/E Ratio
-3.52
Consensus Rating
Buy
Consensus Price Target
$1.54 (+235.7% Upside)
Volume
4.54 million shares
Average Volume
7.89 million shares
Ultrapar Participacoes stock logo

6. Ultrapar Participacoes NYSE:UGP

$3.96 +0.02 (+0.38%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$4.42 billion
P/E Ratio
8.81
Consensus Rating
Buy
Consensus Price Target
$3.20 (-19.3% Downside)
Volume
877,719 shares
Average Volume
1.83 million shares
DoubleDown Interactive stock logo

7. DoubleDown Interactive NASDAQ:DDI

$9.47 +0.16 (+1.72%)
As of 01:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DoubleDown Interactive Co, Ltd. engages in the development and publishing of casual games and mobile applications in South Korea. More about DoubleDown Interactive

Market Capitalization
$469.04 million
P/E Ratio
4.40
Consensus Rating
Buy
Consensus Price Target
$19.25 (+103.3% Upside)
Volume
42,320 shares
Average Volume
49,329 shares
TuHURA Biosciences stock logo

8. TuHURA Biosciences NASDAQ:HURA

$2.57 +0.14 (+5.76%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$128.62 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+392.9% Upside)
Volume
79,195 shares
Average Volume
300,131 shares
Today's Range
$2.45
$2.63
Climb Bio stock logo

9. Climb Bio NASDAQ:CLYM

$2.14 +0.02 (+0.94%)
As of 12:59 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$145.01 million
P/E Ratio
-3.06
Consensus Rating
Buy
Consensus Price Target
$9.00 (+320.6% Upside)
Volume
140,569 shares
Average Volume
361,550 shares
Priority Technology stock logo

10. Priority Technology NASDAQ:PRTH

$7.47 +0.16 (+2.19%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Priority Technology Holdings, Inc operates as a payment technology company in the United States. The company operates through three segments: Small and Medium-Sized Businesses (SMB) Payments, Business-To-Business (B2B) Payments, and Enterprise Payments. More about Priority Technology

Market Capitalization
$596.20 million
P/E Ratio
28.69
Consensus Rating
Buy
Consensus Price Target
$13.00 (+74.0% Upside)
Volume
166,134 shares
Average Volume
564,441 shares
Western Copper & Gold stock logo

11. Western Copper & Gold NYSE:WRN

$1.66 -0.01 (-0.30%)
As of 01:02 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$333.73 million
P/E Ratio
-82.75
Consensus Rating
Buy
Consensus Price Target
$4.00 (+141.7% Upside)
Volume
329,815 shares
Average Volume
389,682 shares
VNET Group stock logo

12. VNET Group NASDAQ:VNET

$9.98 +0.13 (+1.27%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET Group

Market Capitalization
$2.69 billion
P/E Ratio
-124.94
Consensus Rating
Buy
Consensus Price Target
$9.96 (-0.2% Downside)
Volume
4.28 million shares
Average Volume
7.77 million shares
TriSalus Life Sciences stock logo

13. TriSalus Life Sciences NASDAQ:TLSI

$5.00 +0.20 (+4.25%)
As of 01:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$250.08 million
P/E Ratio
-4.25
Consensus Rating
Buy
Consensus Price Target
$10.90 (+117.8% Upside)
Volume
35,645 shares
Average Volume
66,930 shares
Ivanhoe Electric stock logo

14. Ivanhoe Electric NYSEAMERICAN:IE

$9.42 +0.40 (+4.47%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Ivanhoe Electric Inc explores and develops metals and mineral. The company provides Typhoon data acquisition system, a geophysical system that offers primary signal. More about Ivanhoe Electric

Market Capitalization
$1.25 billion
P/E Ratio
-14.74
Consensus Rating
Buy
Consensus Price Target
$14.00 (+48.6% Upside)
Volume
380,970 shares
Average Volume
959,681 shares
908 Devices stock logo

15. 908 Devices NASDAQ:MASS

$6.98 +0.45 (+6.81%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. More about 908 Devices

Market Capitalization
$249.94 million
P/E Ratio
-12.91
Consensus Rating
Buy
Consensus Price Target
$8.00 (+14.7% Upside)
Volume
153,756 shares
Average Volume
1.39 million shares
Mind Medicine (MindMed) stock logo

16. Mind Medicine (MindMed) NASDAQ:MNMD

$9.66 +0.09 (+0.94%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mind Medicine (MindMed) Inc, a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. More about Mind Medicine (MindMed)

Market Capitalization
$737.31 million
P/E Ratio
-6.33
Consensus Rating
Buy
Consensus Price Target
$26.50 (+174.3% Upside)
Volume
463,243 shares
Average Volume
1.46 million shares
Endeavour Silver stock logo

17. Endeavour Silver NYSE:EXK

$6.20 -0.30 (-4.60%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Endeavour Silver Corp., a silver mining company, engages in the acquisition, exploration, development, extraction, processing, refining, and reclamation of mineral properties in Chile and the United States. More about Endeavour Silver

Market Capitalization
$1.81 billion
P/E Ratio
-22.98
Consensus Rating
Buy
Consensus Price Target
$8.33 (+34.4% Upside)
Volume
7.35 million shares
Average Volume
11.79 million shares
Hochschild Mining stock logo

18. Hochschild Mining OTCMKTS:HCHDF

$4.09 -0.23 (-5.22%)
As of 12:41 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.10 billion
Consensus Rating
Buy
Volume
25,201 shares
Average Volume
32,662 shares
Today's Range
$3.99
$4.16
50-Day Range
$3.56
$4.70
Tenax Therapeutics stock logo

19. Tenax Therapeutics NASDAQ:TENX

$6.31 +0.06 (+1.02%)
As of 01:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tenax Therapeutics, Inc develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. More about Tenax Therapeutics

Market Capitalization
$28.68 million
P/E Ratio
-6.83
Consensus Rating
Buy
Consensus Price Target
$18.00 (+185.1% Upside)
Volume
245,924 shares
Average Volume
32,493 shares
Medicus Pharma stock logo

20. Medicus Pharma NASDAQ:MDCX

$2.52 +0.11 (+4.56%)
As of 01:03 PM Eastern

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. More about Medicus Pharma

Market Capitalization
$44.91 million
P/E Ratio
-1.88
Consensus Rating
Buy
Consensus Price Target
$23.50 (+832.5% Upside)
Volume
190,807 shares
Average Volume
237,985 shares
ImmunityBio stock logo

21. ImmunityBio NASDAQ:IBRX

$2.84 +0.08 (+2.72%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.68 billion
P/E Ratio
-5.91
Consensus Rating
Buy
Consensus Price Target
$10.75 (+279.2% Upside)
Volume
6.25 million shares
Average Volume
8.10 million shares
Plus Therapeutics stock logo

22. Plus Therapeutics NASDAQ:PSTV

$0.42 +0.01 (+1.30%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus Therapeutics

Market Capitalization
$41.89 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$7.88 (+1,766.1% Upside)
Volume
5.67 million shares
Average Volume
18.05 million shares
Stardust Power stock logo

23. Stardust Power NASDAQ:SDST

$2.86 -0.04 (-1.21%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$24.19 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$51.13 (+1,684.5% Upside)
Volume
86,668 shares
Average Volume
407,388 shares
United States Antimony stock logo

24. United States Antimony NYSE:UAMY

$5.74 +0.15 (+2.59%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$715.51 million
P/E Ratio
-143.88
Consensus Rating
Buy
Consensus Price Target
$3.38 (-41.3% Downside)
Volume
4.38 million shares
Average Volume
4.14 million shares
Mereo BioPharma Group stock logo

25. Mereo BioPharma Group NASDAQ:MREO

$1.74 +0.02 (+0.87%)
As of 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$277.46 million
P/E Ratio
-24.93
Consensus Rating
Buy
Consensus Price Target
$7.40 (+324.1% Upside)
Volume
573,291 shares
Average Volume
1.65 million shares